Sanofi | SNY - Trade Debtors


Sanofi reported EUR482M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Amgen USD 9.14B 432M Mar/2026
AstraZeneca USD 17.88B 1.17B Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Canopy Growth CAD 36.29M 104.13M Mar/2026
Corcept Therapeutics USD 39.07M 20.71M Mar/2026
Drreddys Laboratories INR 123.17B 121.76B Mar/2026
Eli Lilly USD 21.18B 1.02B Mar/2026
Genmab DKK 1.17B 119M Dec/2025
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Glaxosmithkline GBP 10.49B 40.6M Mar/2026
J&J USD 22.54B 1.21B Mar/2026
Lakefront Biotherapeutics EUR 54.03M 145.72M Mar/2026
Merck USD 11.78B 345M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Novartis USD 9.6B 2.69B Mar/2026
Pacira USD 125.64M 1.57M Mar/2026
Perrigo USD 697.1M 84.3M Mar/2026
Pfizer USD 16.17B 332M Mar/2026
Phibro Animal Health USD 215.87M 2.02M Dec/2025
Prestige Brands USD 191.92M 1.46M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 482M 85M Mar/2026
Sanofi EUR 482M 85M Mar/2026
Supernus Pharmaceuticals USD 182.18M 5.62M Mar/2026
UCB EUR 1.97B 54M Dec/2025
Zoetis USD 1.51B 84M Mar/2026